BeOne Medicines (BEIGF) Share-based Compensation (QoQ) (2015 - 2026)
Powered by 
Analysis
BeOne Medicines (BEIGF) Share-based Compensation (QoQ) (2015 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.93 Bn | 625.17 Bn | 17.26 Bn |
| 2 | AbbVie | 443.06 Bn | 436.49 Bn | 12.70 Bn |
| 3 | Merck | 365.76 Bn | 358.62 Bn | 12.21 Bn |
| 4 | Novartis Ag | 266.47 Bn | 258.78 Bn | 11.24 Bn |
| 5 | Pfizer | 158.57 Bn | 146.88 Bn | 10.94 Bn |
| 6 | Sanofi | 52.36 Bn | 44.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 43.97 Bn | 43.97 Bn | - |
| 8 | Incyte | 25.42 Bn | 20.88 Bn | 1.57 Bn |
| 9 | United Therapeutics | 21.52 Bn | 18.86 Bn | 683.80 Mn |
| 10 | BeOne Medicines | 2.48 Bn | -2.62 Bn | 1.53 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 11.39% |
| Mar 31, 2026 | -0.33% |
| Dec 31, 2025 | -12.11% |
| Sep 30, 2025 | -6.63% |
| Jun 30, 2025 | 57.95% |
| Mar 31, 2025 | -11.28% |
| Dec 31, 2024 | -6.17% |
| Sep 30, 2024 | -12.20% |
| Jun 30, 2024 | 47.33% |
| Mar 31, 2024 | -4.58% |
| Dec 31, 2023 | -3.21% |
| Sep 30, 2023 | -7.13% |
| Jun 30, 2023 | 37.24% |
| Mar 31, 2023 | -3.59% |
| Dec 31, 2022 | -0.06% |
| Sep 30, 2022 | -3.85% |
| Jun 30, 2022 | 24.03% |
| Mar 31, 2022 | 4.04% |
| Dec 31, 2021 | -6.06% |
| Sep 30, 2021 | 3.53% |